Authors: VERSTUYF A SEGAERT S VERLINDEN L CASTEELS K BOUILLON R MATHIEU C

Citation: A. Verstuyf et al., RECENT DEVELOPMENTS IN THE USE OF VITAMIN-D ANALOGS, Current opinion in nephrology and hypertension, 7(4), 1998, pp. 397-403

Authors: VERSTUYF A VERLINDEN L VANBAELEN H SABBE K DHALLEWYN C DECLERCQ P VANDEWALLE M BOUILLON R

Citation: A. Verstuyf et al., THE BIOLOGICAL-ACTIVITY OF NONSTEROIDAL VITAMIN-D HORMONE ANALOGS LACKING BOTH THE C-RINGS AND D-RINGS, Journal of bone and mineral research, 13(4), 1998, pp. 549-558

Authors: VERLINDEN L VERSTUYF A CONVENTS R MARCELIS S VANCAMP M BOUILLON R

Citation: L. Verlinden et al., ACTION OF 1,25(OH)(2)D-3 ON THE CELL-CYCLE GENES, CYCLIN D1, P21 AND P27 IN MCF-7 CELLS, Molecular and cellular endocrinology, 142(1-2), 1998, pp. 57-65

Authors: VERLINDEN L VERSTUYF A MATHIEU C TAN BK BOUILLON R

Citation: L. Verlinden et al., DIFFERENTIATION INDUCTION OF HL60 CELLS BY 1,25(OH)(2)D-3, ALL-TRANS-RETINOIC ACID, RTGF-BETA(2) AND THEIR COMBINATIONS, Journal of steroid biochemistry and molecular biology, 60(1-2), 1997, pp. 87-97

Authors: VERSTUYF A MATHIEU C VERLINDEN L WAER M TAN BK BOUILLON R

Citation: A. Verstuyf et al., DIFFERENTIATION INDUCTION OF HUMAN LEUKEMIA-CELLS (HL-60) BY A COMBINATION OF 1,25-DIHYDROXYVITAMIN D-3 AND RETINOIC ACID (ALL-TRANS OR 9-CIS), Journal of steroid biochemistry and molecular biology, 53(1-6), 1995, pp. 431-441

Authors: BOUILLON R VERSTUYF A VERLINDEN L ALLEWAERT K BRANISTEANU D MATHIEU C VANBAELEN H

Citation: R. Bouillon et al., NON-HYPERCALCEMIC PHARMACOLOGICAL ASPECTS OF VITAMIN-D ANALOGS, Biochemical pharmacology, 50(5), 1995, pp. 577-583